Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 2/2002

01-04-2002 | Original Article

Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma

Authors: Bernhard Kremens, Barbara Hero, Joachim Esser, Peter Weinel, Judith Filger-Brillinger, Gudrun Fleischhack, Norbert Graf, Hans-Peter Grüttner, Charlotte Niemeyer, Ansgar Schulz, Lutz Wickmann, Frank Berthold

Published in: Cancer Immunology, Immunotherapy | Issue 2/2002

Login to get access
Metadata
Title
Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma
Authors
Bernhard Kremens
Barbara Hero
Joachim Esser
Peter Weinel
Judith Filger-Brillinger
Gudrun Fleischhack
Norbert Graf
Hans-Peter Grüttner
Charlotte Niemeyer
Ansgar Schulz
Lutz Wickmann
Frank Berthold
Publication date
01-04-2002
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 2/2002
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-001-0259-x

Other articles of this Issue 2/2002

Cancer Immunology, Immunotherapy 2/2002 Go to the issue

Original Article

Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy

Original Article

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

Original Article

Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia

Original Article

Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface

Original Article

Cloning, isolation and characterization of human tumor in situ monoclonal antibodies

Original Article

Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits